All the news Showing 10 of 34 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Novel methods of non-invasive testing for non-alcoholic fatty liver disease EASL / 28 August 2020 Liver fibrosis assessment in routine care for diabetic patients could uncover a hidden population of people living with advanced liver disease EASL / 28 August 2020 Two novel treatments show promise in improving biomarkers of NASH pathology EASL / 28 August 2020 Fatty Liver Disease Tied to Metabolic Health Conditions in People With HIV Poz / 24 August 2020 Diabetes More Than Doubles Risk of Advanced Liver Disease HepMag / 27 July 2020 Women Suffer Less NAFLD but More Advanced Fibrosis Medscape (requires free registration) / 27 July 2020 Global Liver Institute’s International NASH Day Convenes 80 Partner Organizations and 30 Speakers to Declare Urgency of Combatting Parallel Epidemics of Liver Disease and COVID-19 Global LIver Institute / 15 June 2020 'Another swing, another miss' for Gilead as NASH combo flops in phase 2 Fierce Biotech / 16 December 2019 Gilead Announces Topline Results From Phase 2 ATLAS Study in Patients With Bridging Fibrosis (F3) and Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) Gilead press release / 16 December 2019 Fatty livers halt tumor-suppressing protein, increasing cancer risk Fierce Biotech / 21 October 2019 ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD NASH Experimental treatments for NASH/NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds